CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 650 of 764 entries

View as:

Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)

Phase: N/A Priority: Normal

NCT ID: NCT05849675 Org: User:

Start: 04/01/23 End: 05/08/24 Due: 05/08/25

Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria

Phase: N/A Priority: Normal

NCT ID: NCT00692627 Org: User:

Start: 07/31/08 End: 12/31/08 Due: 12/31/09

A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours

Phase: N/A Priority: Normal

NCT ID: NCT01432145 Org: User:

Start: 05/31/11 End: 05/31/15 Due: 05/31/16

A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both

Phase: N/A Priority: Normal

NCT ID: NCT00480558 Org: User:

Start: 07/31/07 End: 01/31/11 Due: 01/31/12

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06658782 Org: User:

Start: 12/01/24 End: 04/30/39 Due: 04/30/40

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)

Phase: N/A Priority: Normal

NCT ID: NCT02739763 Org: User:

Start: 05/31/16 End: 11/30/20 Due: 11/30/21

Type 2 Diabetes: Risk Perceptions and Self-management Behaviour

Phase: N/A Priority: Normal

NCT ID: NCT03840850 Org: User:

Start: 09/15/17 End: 02/09/18 Due: 02/09/19

Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

Phase: N/A Priority: Normal

NCT ID: NCT06799234 Org: User:

Start: 02/28/25 End: 02/28/27 Due: 02/28/28

Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One

Phase: N/A Priority: Normal

NCT ID: NCT01546935 Org: User:

Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Total Hip Replacement Performance & Assessment

Phase: N/A Priority: Normal

NCT ID: NCT04267172 Org: User:

Start: 02/26/20 End: 02/28/22 Due: 02/28/23

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

Phase: N/A Priority: Normal

NCT ID: NCT03762499 Org: User:

Start: 10/02/18 End: 10/02/28 Due: 10/02/29

Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception

Phase: N/A Priority: Normal

NCT ID: NCT01985750 Org: User:

Start: 11/30/13 End: 02/29/20 Due: 02/28/21

Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing

Phase: N/A Priority: Normal

NCT ID: NCT03688048 Org: User:

Start: 02/20/17 End: 03/16/18 Due: 03/16/19

A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B

Phase: N/A Priority: Normal

NCT ID: NCT02600975 Org: User:

Start: 12/08/15 End: 01/19/17 Due: 01/19/18

Oxford Social Movement Activation Study

Phase: N/A Priority: Normal

NCT ID: NCT05963581 Org: User:

Start: 07/17/23 End: 02/28/24 Due: 02/28/25

P.Vivax Treatment Trial

Phase: N/A Priority: Normal

NCT ID: NCT02802813 Org: User:

Start: 06/14/16 End: 06/15/18 Due: 06/15/19

Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

Phase: N/A Priority: Normal

NCT ID: NCT05385510 Org: User:

Start: 01/10/23 End: 09/30/25 Due: 09/30/26

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Phase: N/A Priority: Normal

NCT ID: NCT03140774 Org: User:

Start: 05/17/17 End: 07/10/20 Due: 07/10/21

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Phase: N/A Priority: Normal

NCT ID: NCT05041907 Org: User:

Start: 09/30/21 End: 01/31/27 Due: 01/31/28

PF-04995274 and Emotional Processing in Treatment Resistant Depression

Phase: N/A Priority: Normal

NCT ID: NCT03515733 Org: User:

Start: 05/31/18 End: 07/26/22 Due: 07/26/23

Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation

Phase: N/A Priority: Normal

NCT ID: NCT03183258 Org: User:

Start: 05/19/16 End: 10/01/20 Due: 10/01/21

Recruitment Manoeuvres in Critically Ill Patients

Phase: N/A Priority: Normal

NCT ID: NCT05508724 Org: User:

Start: 10/01/22 End: 12/01/24 Due: 12/01/25

Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Phase: N/A Priority: Normal

NCT ID: NCT04162600 Org: User:

Start: 01/02/20 End: 07/10/24 Due: 07/10/25

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Phase: N/A Priority: Normal

NCT ID: NCT04270838 Org: User:

Start: 02/17/22 End: 09/30/28 Due: 09/30/29

Evidence Based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU)

Phase: N/A Priority: Normal

NCT ID: NCT06666738 Org: User:

Start: 11/30/24 End: 09/30/25 Due: 09/30/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)	NCT05849675	University of Oxford	user2@example.com	None	2023-04-01	2024-05-08	2025-05-08	-	-	2025-07-14
Evaluation of Volume Status, Haemodynamics and Microcirculatory Flow in Adult Patients With Severe Falciparum Malaria	NCT00692627	University of Oxford	user2@example.com	None	2008-07-31	2008-12-31	2009-12-31	-	-	2025-07-14
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours	NCT01432145	University of Oxford	user2@example.com	None	2011-05-31	2015-05-31	2016-05-31	-	-	2025-07-14
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both	NCT00480558	University of Oxford	user2@example.com	None	2007-07-31	2011-01-31	2012-01-31	-	-	2025-07-14
Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer	NCT06658782	University of Oxford	user2@example.com	None	2024-12-01	2039-04-30	2040-04-30	-	-	2025-07-14
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)	NCT02739763	University of Oxford	user2@example.com	None	2016-05-31	2020-11-30	2021-11-30	-	-	2025-07-14
Type 2 Diabetes: Risk Perceptions and Self-management Behaviour	NCT03840850	University of Oxford	user2@example.com	None	2017-09-15	2018-02-09	2019-02-09	-	-	2025-07-14
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)	NCT06799234	University of Oxford	user2@example.com	None	2025-02-28	2027-02-28	2028-02-28	-	-	2025-07-14
Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One	NCT01546935	University of Oxford	user2@example.com	None	2012-12-31	2014-12-31	2015-12-31	-	-	2025-07-14
Total Hip Replacement Performance & Assessment	NCT04267172	University of Oxford	user2@example.com	None	2020-02-26	2022-02-28	2023-02-28	-	-	2025-07-14
Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.	NCT03762499	University of Oxford	user2@example.com	None	2018-10-02	2028-10-02	2029-10-02	-	-	2025-07-14
Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception	NCT01985750	University of Oxford	user2@example.com	None	2013-11-30	2020-02-29	2021-02-28	-	-	2025-07-14
Effects of a Single Dose of Bright Light Treatment on Measures of Affective Information Processing	NCT03688048	University of Oxford	user2@example.com	None	2017-02-20	2018-03-16	2019-03-16	-	-	2025-07-14
A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B	NCT02600975	University of Oxford	user2@example.com	None	2015-12-08	2017-01-19	2018-01-19	-	-	2025-07-14
Oxford Social Movement Activation Study	NCT05963581	University of Oxford	user2@example.com	None	2023-07-17	2024-02-28	2025-02-28	-	-	2025-07-14
P.Vivax Treatment Trial	NCT02802813	University of Oxford	user2@example.com	None	2016-06-14	2018-06-15	2019-06-15	-	-	2025-07-14
Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV	NCT05385510	University of Oxford	user2@example.com	None	2023-01-10	2025-09-30	2026-09-30	-	-	2025-07-14
Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines	NCT03140774	University of Oxford	user2@example.com	None	2017-05-17	2020-07-10	2021-07-10	-	-	2025-07-14
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)	NCT05041907	University of Oxford	user2@example.com	None	2021-09-30	2027-01-31	2028-01-31	-	-	2025-07-14
PF-04995274 and Emotional Processing in Treatment Resistant Depression	NCT03515733	University of Oxford	user2@example.com	None	2018-05-31	2022-07-26	2023-07-26	-	-	2025-07-14
Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation	NCT03183258	University of Oxford	user2@example.com	None	2016-05-19	2020-10-01	2021-10-01	-	-	2025-07-14
Recruitment Manoeuvres in Critically Ill Patients	NCT05508724	University of Oxford	user2@example.com	None	2022-10-01	2024-12-01	2025-12-01	-	-	2025-07-14
Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG	NCT04162600	University of Oxford	user2@example.com	None	2020-01-02	2024-07-10	2025-07-10	-	-	2025-07-14
A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG	NCT04270838	University of Oxford	user2@example.com	None	2022-02-17	2028-09-30	2029-09-30	-	-	2025-07-14
Evidence Based QUality Improvement for Prescribing Stewardship in ICU (EQUIPS-ICU)	NCT06666738	University of Oxford	user2@example.com	None	2024-11-30	2025-09-30	2026-09-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance